AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: pharma investmentClear filter
industryForbes

Inside Incyte’s $120 Million AI Drug Development Deal

Forbes reports that Incyte’s latest AI-for-drug-development agreement is worth $120 million, highlighting how quickly these collaborations are growing in size and ambition. The deal reflects a market where pharma is increasingly willing to pay for access to AI-driven discovery capacity.

IncyteAI dealdrug developmentpharma investment

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.